Nalaganje...
Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
Omalizumab is a recombinant humanized monoclonal antibody that blocks the high-affinity Fc receptor of IgE. Omalizumab has been approved for the treatment of moderate to severe asthma; however, there is currently more and more data showing promising results in the management also of chronic urticari...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3322628/ https://ncbi.nlm.nih.gov/pubmed/22493579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000336205 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|